AU2002224596A1 - Preventives or remedies for obesity or fatty liver - Google Patents
Preventives or remedies for obesity or fatty liverInfo
- Publication number
- AU2002224596A1 AU2002224596A1 AU2002224596A AU2459602A AU2002224596A1 AU 2002224596 A1 AU2002224596 A1 AU 2002224596A1 AU 2002224596 A AU2002224596 A AU 2002224596A AU 2459602 A AU2459602 A AU 2459602A AU 2002224596 A1 AU2002224596 A1 AU 2002224596A1
- Authority
- AU
- Australia
- Prior art keywords
- preventives
- remedies
- obesity
- fatty liver
- liver
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000233072 | 2000-08-01 | ||
JP2000-233072 | 2000-08-01 | ||
PCT/JP2001/006532 WO2002009757A1 (fr) | 2000-08-01 | 2001-07-30 | Agents de prevention ou remedes contre l'obesite ou la steatose hepatique |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002224596A1 true AU2002224596A1 (en) | 2002-02-13 |
Family
ID=18725654
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002224596A Abandoned AU2002224596A1 (en) | 2000-08-01 | 2001-07-30 | Preventives or remedies for obesity or fatty liver |
Country Status (7)
Country | Link |
---|---|
US (1) | US20030153513A1 (de) |
EP (2) | EP1306094A4 (de) |
KR (1) | KR20030036658A (de) |
CN (1) | CN1466465A (de) |
AU (1) | AU2002224596A1 (de) |
CA (1) | CA2417492A1 (de) |
WO (1) | WO2002009757A1 (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2006249350B2 (en) | 2003-11-19 | 2012-02-16 | Metabasis Therapeutics, Inc. | Thyromimetics for the treatment of fatty liver diseases |
EP2428516A1 (de) * | 2003-11-19 | 2012-03-14 | Metabasis Therapeutics, Inc. | Neue Phosphor enthaltende Thyromimetika |
WO2006128056A2 (en) * | 2005-05-26 | 2006-11-30 | Metabasis Therapeutics, Inc. | Novel phosphinic acid-containing thyromimetics |
US8524212B2 (en) | 2007-10-24 | 2013-09-03 | Mitsubishi Tanabe Pharma Corporation | Prophylactic and/or therapeutic drug for nonalcoholic steatohepatitis |
CN101969944B (zh) * | 2008-01-31 | 2013-04-10 | 安斯泰来制药有限公司 | 脂肪性肝病的治疗用医药组合物 |
CA2738985A1 (en) * | 2008-09-30 | 2010-04-08 | Mochida Pharmaceutical Co., Ltd. | Therapeutic agent for hepatitis c |
WO2010062861A2 (en) * | 2008-11-26 | 2010-06-03 | Satiogen Pharmaceuticals, Inc. | Bile acid recycling inhibitors for treatment of obesity and diabetes |
EP2995317A1 (de) | 2010-05-26 | 2016-03-16 | Satiogen Pharmaceuticals, Inc. | Gallensäurerückflusshemmer zur behandlung von diabetes, adipositas und entzündlichen magen-darm-erkrankungen |
JP6158720B2 (ja) * | 2014-02-19 | 2017-07-05 | 国立大学法人神戸大学 | 表面処理剤、表面処理ポリアミド逆浸透膜及びその製造方法 |
CN106176800B (zh) * | 2016-07-11 | 2019-12-06 | 韩源平 | 多聚阳离子树脂的制药应用 |
MX2019005730A (es) | 2016-11-21 | 2019-10-21 | Viking Therapeutics Inc | Metodo para tratar enfermedad de almacenamiento de glucogeno. |
EA201992703A1 (ru) | 2017-06-05 | 2020-04-15 | Вайкинг Терапьютикс, Инк. | Композиции для лечения фиброза |
KR101844184B1 (ko) | 2017-07-21 | 2018-04-02 | 씨제이헬스케어 주식회사 | 아미노알킬벤조티아제핀 유도체의 용도 |
AU2019238090A1 (en) | 2018-03-22 | 2020-10-08 | Viking Therapeutics, Inc. | Crystalline forms and methods of producing crystalline forms of a compound |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1209138A (en) * | 1969-06-13 | 1970-10-21 | Pharma Chemie | IMPROVEMENTS IN OR RELATING TO A NEW alpha-NAPHTHOXY-ISOBUTYRIC ACID DERIVATIVE, PROCESS FOR ITS PREPARATION AND THERAPEUTICAL COMPOSITION CONTAINING SAME |
IT1052819B (it) * | 1975-12-12 | 1981-07-20 | Fargal Pharmasint Lab Biochim | Preparato inibitore dell assorbimento dei lipidi a base di dietilamminoetildestrano |
ATE175954T1 (de) * | 1991-10-17 | 1999-02-15 | Shionogi & Co | Verfahren zum herstellen von lignin-analoga und ausgangsprodukte dafür |
JP3556962B2 (ja) * | 1993-03-30 | 2004-08-25 | 雪印乳業株式会社 | 脂肪肝抑制剤 |
JPH09241206A (ja) * | 1996-03-01 | 1997-09-16 | Shionogi & Co Ltd | リグナン系化合物 |
JP2001514667A (ja) * | 1997-03-17 | 2001-09-11 | タム,ユン ケー. | 肝臓脂肪症の予防のための組成物 |
-
2001
- 2001-07-30 KR KR10-2003-7001367A patent/KR20030036658A/ko not_active Application Discontinuation
- 2001-07-30 WO PCT/JP2001/006532 patent/WO2002009757A1/ja not_active Application Discontinuation
- 2001-07-30 EP EP01984401A patent/EP1306094A4/de not_active Withdrawn
- 2001-07-30 AU AU2002224596A patent/AU2002224596A1/en not_active Abandoned
- 2001-07-30 US US10/343,460 patent/US20030153513A1/en not_active Abandoned
- 2001-07-30 EP EP06024179A patent/EP1749539A2/de not_active Withdrawn
- 2001-07-30 CN CNA018162983A patent/CN1466465A/zh active Pending
- 2001-07-30 CA CA002417492A patent/CA2417492A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
KR20030036658A (ko) | 2003-05-09 |
CN1466465A (zh) | 2004-01-07 |
EP1306094A1 (de) | 2003-05-02 |
EP1749539A2 (de) | 2007-02-07 |
CA2417492A1 (en) | 2003-01-28 |
WO2002009757A1 (fr) | 2002-02-07 |
US20030153513A1 (en) | 2003-08-14 |
EP1306094A4 (de) | 2006-04-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001246876A1 (en) | Remedies | |
AU2001246877A1 (en) | Remedies | |
AU2473401A (en) | Organosiloxane compositions | |
AU2002246666A1 (en) | Anti-icing composition | |
AU2001250420A1 (en) | Pharmaceutical compositions | |
AU2001241095A1 (en) | Preventives and/or remedies for hyperphosphatemia | |
AU2001230894A1 (en) | Pro-perfume composition | |
AU1530001A (en) | Inhibitor compositions | |
AU2002224596A1 (en) | Preventives or remedies for obesity or fatty liver | |
AUPQ875700A0 (en) | Combination compositions | |
AU2002214324A1 (en) | Medicinal compositions | |
AU3170099A (en) | Remedies for obesity | |
AU2001249675A1 (en) | Fatty quat based on ante-iso compounds | |
AU2001241098A1 (en) | Composition | |
AU3987800A (en) | Preventives/remedies for angiostenosis | |
AU2001232271A1 (en) | Preventives/remedies for postoperative stress | |
AU2002222676A1 (en) | Preventives or remedies for endometriosis | |
AU2001275201A1 (en) | Acne-treating composition | |
AU2001275043A1 (en) | Mineral supplement | |
AU2001287852A1 (en) | Composition | |
AU2001235764A1 (en) | Compositions | |
AU2002359916A1 (en) | Preventives/remedies for cancer | |
AU2003236039A1 (en) | Preventives/remedies for hotflash | |
AU2001295952A1 (en) | Novel remedies or preventives for angiostenosis | |
AU2001252578A1 (en) | Preventives for influenza |